IP Verse

Kilburn & Strode patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Kilburn & Strode opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Kilburn & Strode

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4188491	Dry Powder Medicament Inhaler	NORTON WATERFORD	Feb 8, 2025	KILBURN & STRODE
EP3335707	Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist	GLAXO GROUP	Jan 17, 2025	KILBURN & STRODE
EP3090730	Novel Pharmaceutical Composition	NOVARTIS	Jan 10, 2025	KILBURN & STRODE
EP3494972	Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection	VIIV HEALTHCARE	Sep 12, 2024	KILBURN & STRODE
EP3590949	Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof	MODERNATX	Feb 17, 2023	KILBURN & STRODE
EP3407945	Method For Measuring Flow Features In An Inhaler, Inhaler And System	NOVARTIS	Feb 6, 2023	KILBURN & STRODE
EP3363485	Metered Dose Inhaler	PRESSPART	Jan 19, 2023	KILBURN & STRODE
EP2791160	Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions	MODERNA THERAPEUTICS	Dec 2, 2022	KILBURN & STRODE
EP3209783	Permanent Epigenetic Gene Silencing	OSPEDALE SAN RAFFAELE	Aug 24, 2022	JAMES POOLE
EP3401335	Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof	GENENTECH	Mar 30, 2022	EUROPEAN OPPOSITIONS

Top companies who are the clients of Kilburn & Strode